MedAvail Holdings, Inc.
MDVLDelisted Mar 21, 2024- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001402479
MedAvail Holdings, Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 6, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $6.16M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 21
- Q4 2023, +2 vs. previous quarter
- 13F value
- $6.16M
- Reported value at the end of Q4 2023
- Superinvestors holding
- 0
- At the end of Q4 2023
Superinvestors holding MDVL, Q4 2023
No superinvestor reported holding MDVL at the end of Q4 2023.
Latest insider trades
Open-market purchases and sales by MedAvail Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 (view filing) | Sep 28 | 4 days | Seabaugh RamonaChief Financial Officer | SSale | −303 | $5.70 | −$1.73K | −19.9%1.22K after | 10b5-1 |
| Mar 23, 2023 (view filing)8:16 PM ET | Mar 21 | 2 days | Seabaugh RamonaChief Financial Officer | SSale | −3.29K | $0.307 | −$1.01K | −15.2%18.3K after | |
| Mar 15, 2023 (view filing)4:30 PM ET | Mar 13 | 2 days | Yu Fan and 7 others10% Owner | PPurchase | +7.78M | $0.3212 | +$2.50M | –965.1K after | Derivative2 lots |
| Mar 7, 2023 (view filing)7:55 PM ET | Mar 3 | 4 days | Seabaugh RamonaChief Financial Officer | SSale | −6.73K | $0.3366 | −$2.26K | −23.7%21.6K after | |
| Mar 7, 2023 (view filing)7:54 PM ET | Mar 3-6 | 4 days | Doerr Mark EdwardChief Executive Officer | SSale | −93.6K | $0.3145 | −$29.4K | −33.1%188.7K after | 2 lots |
| Apr 6, 2022 (view filing)4:30 PM ET | Apr 4 | 2 days | Yu Fan and 7 others10% Owner | PPurchase | +14.1M | $1.06 | +$15.0M | New position5.89M after | 2 lots |
| Apr 6, 2022 (view filing)4:30 PM ET | Apr 4 | 2 days | Yu Fan and 7 others10% Owner | PPurchase | +7.06M | $1.06 | +$7.50M | –1.49M after | Derivative2 lots |
Top 10 13F holders, Q4 2023
The largest institutional positions in MedAvail Holdings, Inc. at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmile Group, LLC | 692,082 | $3.05M | 0.11% | 00.0% | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 300,588 | $1.35M | 2.63% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 117,897 | $529.4K | 0.38% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 87,618 | $393.4K | 0.00% | −28,682−24.7% | Reduced |
| Pura Vida Investments, LLC | 58,070 | $327.8K | 0.36% | 00.0% | Unchanged |
| Cigna Investments Inc | 47,789 | $211.0K | 0.04% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 20,000 | $89.8K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 16,732 | $75.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 14,031 | $63.0K | 0.00% | −6,990−33.3% | Reduced |
| HRT Financial LP | 10,618 | $46.0K | 0.00% | +10,618 | New |